secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001818331-22-000022
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sema4 President and COO James Coffin departs; gets $550K severance, bonus, option acceleration
--------------------------------------------------------------------------------

- James Coffin, President and COO, leaves for personal reasons effective Feb 1, 2022.
- Separation agreement includes $550,000 cash severance (12 months base salary) and $180,370 bonus.
- COBRA premiums reimbursed for up to 12 months; accelerated vesting of 25,425 stock options.
- Extended post-termination exercise period for vested options through May 30, 2022.
- CEO Eric Schadt will absorb Coffin's responsibilities; no successor named.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833122000022/0001818331-22-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833122000022/smfr-20220125.htm
  HTML page:      https://secwatch.observer/filing/0001818331-22-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer